Molecular Partners AG (MOLN)
3.87
+0.09
(+2.35%)
USD |
NASDAQ |
May 01, 16:00
4.40
+0.53
(+13.70%)
After-Hours: 20:00
Molecular Partners Price: 3.87 for May 1, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 01, 2024 | 3.765 | 4.272 | 3.60 | 3.87 | 4917.00 |
| Apr 30, 2024 | 3.97 | 3.97 | 3.78 | 3.781 | 4726.00 |
| Apr 29, 2024 | 3.60 | 3.96 | 3.60 | 3.70 | 2558.00 |
| Apr 26, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 254.00 |
| Apr 25, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 0.000 |
| Apr 24, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 0.000 |
| Apr 23, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 0.000 |
| Apr 22, 2024 | 3.721 | 3.89 | 3.721 | 3.88 | 3548.00 |
| Apr 19, 2024 | 3.67 | 3.775 | 3.32 | 3.32 | 6210.00 |
| Apr 18, 2024 | 3.74 | 3.74 | 3.74 | 3.74 | 319.00 |
| Apr 17, 2024 | 3.91 | 3.91 | 3.91 | 3.91 | 0.000 |
| Apr 16, 2024 | 3.93 | 3.94 | 3.78 | 3.91 | 3162.00 |
| Apr 15, 2024 | 3.95 | 3.95 | 3.95 | 3.95 | 6584.00 |
| Apr 12, 2024 | 3.835 | 4.90 | 3.61 | 3.95 | 13546.00 |
| Apr 11, 2024 | 3.98 | 4.05 | 3.85 | 3.86 | 25476.00 |
| Apr 10, 2024 | 3.86 | 4.181 | 3.85 | 4.06 | 2949.00 |
| Apr 09, 2024 | 3.96 | 3.96 | 3.96 | 3.96 | 0.000 |
| Apr 08, 2024 | 3.886 | 3.97 | 3.886 | 3.96 | 7580.00 |
| Apr 05, 2024 | 4.12 | 4.15 | 3.95 | 3.95 | 7849.00 |
| Apr 04, 2024 | 3.95 | 3.972 | 3.90 | 3.91 | 15387.00 |
| Apr 03, 2024 | 3.82 | 4.048 | 3.781 | 4.048 | 3327.00 |
| Apr 02, 2024 | 3.90 | 3.90 | 3.90 | 3.90 | 1067.00 |
| Apr 01, 2024 | 4.20 | 4.20 | 4.20 | 4.20 | 0.000 |
| Mar 28, 2024 | 4.20 | 4.20 | 4.20 | 4.20 | 0.000 |
| Mar 27, 2024 | 4.08 | 4.20 | 4.04 | 4.20 | 2231.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.32
Minimum
Apr 19 2024
31.89
Maximum
Jan 14 2022
10.09
Average
6.55
Median
Price Benchmarks
| AC Immune SA | 2.49 |
| CRISPR Therapeutics AG | 53.79 |
| Addex Therapeutics Ltd | 8.110 |
| NLS Pharmaceutics Ltd | 0.1339 |
| MoonLake Immunotherapeutics | 42.82 |
Price Related Metrics
| PS Ratio | 16.27 |
| Price to Book Value | 0.6053 |
| Earnings Yield | -54.38% |
| Market Cap | 127.15M |